| pubmed-article:19903807 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19903807 | lifeskim:mentions | umls-concept:C0027819 | lld:lifeskim |
| pubmed-article:19903807 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
| pubmed-article:19903807 | lifeskim:mentions | umls-concept:C0079419 | lld:lifeskim |
| pubmed-article:19903807 | lifeskim:mentions | umls-concept:C0812222 | lld:lifeskim |
| pubmed-article:19903807 | lifeskim:mentions | umls-concept:C0231491 | lld:lifeskim |
| pubmed-article:19903807 | lifeskim:mentions | umls-concept:C1435338 | lld:lifeskim |
| pubmed-article:19903807 | pubmed:issue | 22 | lld:pubmed |
| pubmed-article:19903807 | pubmed:dateCreated | 2009-11-20 | lld:pubmed |
| pubmed-article:19903807 | pubmed:abstractText | Restoring p53 function by antagonizing its interaction with the negative regulator MDM2 is an appealing nongenotoxic approach to treating tumors with wild-type p53. Mutational inactivation of p53 is rare in neuroblastoma tumors at diagnosis and occurs in only a subset of multidrug-resistant neuroblastomas. | lld:pubmed |
| pubmed-article:19903807 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19903807 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19903807 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19903807 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19903807 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19903807 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19903807 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19903807 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19903807 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19903807 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19903807 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19903807 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19903807 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19903807 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19903807 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19903807 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:19903807 | pubmed:issn | 1460-2105 | lld:pubmed |
| pubmed-article:19903807 | pubmed:author | pubmed-author:CinatlJindric... | lld:pubmed |
| pubmed-article:19903807 | pubmed:author | pubmed-author:MarineJean-Ch... | lld:pubmed |
| pubmed-article:19903807 | pubmed:author | pubmed-author:De PaepeAnneA | lld:pubmed |
| pubmed-article:19903807 | pubmed:author | pubmed-author:SpelemanFrank... | lld:pubmed |
| pubmed-article:19903807 | pubmed:author | pubmed-author:MichaelisMart... | lld:pubmed |
| pubmed-article:19903807 | pubmed:author | pubmed-author:VandesompeleJ... | lld:pubmed |
| pubmed-article:19903807 | pubmed:author | pubmed-author:CuvelierClaud... | lld:pubmed |
| pubmed-article:19903807 | pubmed:author | pubmed-author:BrackeMarcM | lld:pubmed |
| pubmed-article:19903807 | pubmed:author | pubmed-author:YigitNurtenN | lld:pubmed |
| pubmed-article:19903807 | pubmed:author | pubmed-author:Van... | lld:pubmed |
| pubmed-article:19903807 | pubmed:author | pubmed-author:LambertzIrina... | lld:pubmed |
| pubmed-article:19903807 | pubmed:author | pubmed-author:FerdinandeLie... | lld:pubmed |
| pubmed-article:19903807 | pubmed:author | pubmed-author:TaildemanJasm... | lld:pubmed |
| pubmed-article:19903807 | pubmed:author | pubmed-author:VercruysseLie... | lld:pubmed |
| pubmed-article:19903807 | pubmed:author | pubmed-author:RihaniAliA | lld:pubmed |
| pubmed-article:19903807 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19903807 | pubmed:day | 18 | lld:pubmed |
| pubmed-article:19903807 | pubmed:volume | 101 | lld:pubmed |
| pubmed-article:19903807 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19903807 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19903807 | pubmed:pagination | 1562-74 | lld:pubmed |
| pubmed-article:19903807 | pubmed:meshHeading | pubmed-meshheading:19903807... | lld:pubmed |
| pubmed-article:19903807 | pubmed:meshHeading | pubmed-meshheading:19903807... | lld:pubmed |
| pubmed-article:19903807 | pubmed:meshHeading | pubmed-meshheading:19903807... | lld:pubmed |
| pubmed-article:19903807 | pubmed:meshHeading | pubmed-meshheading:19903807... | lld:pubmed |
| pubmed-article:19903807 | pubmed:meshHeading | pubmed-meshheading:19903807... | lld:pubmed |
| pubmed-article:19903807 | pubmed:meshHeading | pubmed-meshheading:19903807... | lld:pubmed |
| pubmed-article:19903807 | pubmed:meshHeading | pubmed-meshheading:19903807... | lld:pubmed |
| pubmed-article:19903807 | pubmed:meshHeading | pubmed-meshheading:19903807... | lld:pubmed |
| pubmed-article:19903807 | pubmed:meshHeading | pubmed-meshheading:19903807... | lld:pubmed |
| pubmed-article:19903807 | pubmed:meshHeading | pubmed-meshheading:19903807... | lld:pubmed |
| pubmed-article:19903807 | pubmed:meshHeading | pubmed-meshheading:19903807... | lld:pubmed |
| pubmed-article:19903807 | pubmed:meshHeading | pubmed-meshheading:19903807... | lld:pubmed |
| pubmed-article:19903807 | pubmed:meshHeading | pubmed-meshheading:19903807... | lld:pubmed |
| pubmed-article:19903807 | pubmed:meshHeading | pubmed-meshheading:19903807... | lld:pubmed |
| pubmed-article:19903807 | pubmed:meshHeading | pubmed-meshheading:19903807... | lld:pubmed |
| pubmed-article:19903807 | pubmed:meshHeading | pubmed-meshheading:19903807... | lld:pubmed |
| pubmed-article:19903807 | pubmed:meshHeading | pubmed-meshheading:19903807... | lld:pubmed |
| pubmed-article:19903807 | pubmed:meshHeading | pubmed-meshheading:19903807... | lld:pubmed |
| pubmed-article:19903807 | pubmed:meshHeading | pubmed-meshheading:19903807... | lld:pubmed |
| pubmed-article:19903807 | pubmed:meshHeading | pubmed-meshheading:19903807... | lld:pubmed |
| pubmed-article:19903807 | pubmed:meshHeading | pubmed-meshheading:19903807... | lld:pubmed |
| pubmed-article:19903807 | pubmed:meshHeading | pubmed-meshheading:19903807... | lld:pubmed |
| pubmed-article:19903807 | pubmed:meshHeading | pubmed-meshheading:19903807... | lld:pubmed |
| pubmed-article:19903807 | pubmed:meshHeading | pubmed-meshheading:19903807... | lld:pubmed |
| pubmed-article:19903807 | pubmed:meshHeading | pubmed-meshheading:19903807... | lld:pubmed |
| pubmed-article:19903807 | pubmed:meshHeading | pubmed-meshheading:19903807... | lld:pubmed |
| pubmed-article:19903807 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19903807 | pubmed:articleTitle | Antitumor activity of the selective MDM2 antagonist nutlin-3 against chemoresistant neuroblastoma with wild-type p53. | lld:pubmed |
| pubmed-article:19903807 | pubmed:affiliation | Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium. tom.vanmaerken@ugent.be | lld:pubmed |
| pubmed-article:19903807 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19903807 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19903807 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19903807 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19903807 | lld:pubmed |
